Capecitabine and oxaliplatin in patients with advanced or metastatic pancreatic adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 26 Feb 2017 Status changed from active, no longer recruiting to completed.
- 23 Feb 2017 Planned End Date changed from 1 Nov 2016 to 1 Nov 2017.
- 30 Aug 2016 Planned End Date changed from 1 Jul 2016 to 1 Nov 2016.